Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
ASTRO
May 30, 2024, 10:35 |
Career
Rachna Shroff: University of Arizona Cancer Center is hiring!
Rachna Shroff shared on X: "University of Arizona Cancer Center is hiring! We are looking…
May 30, 2024, 08:48 |
Blog
Douglas Flora: It was an absolute pleasure to interview one of my idols, Dr. Karen Knudsen
Douglas Flora shared a post on LinkedIn: "Ahead of Print: It was an absolute pleasure to…
May 30, 2024, 02:17 |
Societies
ASCO24 Pro Tip by Miriam Knoll
Miriam Knoll shared on X: "ASCO24 Pro Tip: If you're looking for a job, scout…
May 29, 2024, 17:11 |
Positive
Asya Agulnik Receives 2024 Yvonne Award in the Leadership Category
Yvonne Award Winners 2024 by OncoDaily We are excited to announce the esteemed winners of…
May 29, 2024, 14:01 |
Positive
Pashtoon Kasi and Erica Tsang Receive 2024 Yvonne Award in the Challenging the Status Quo Category
Yvonne Award Winners 2024 by OncoDaily We are excited to announce the esteemed winners of…
May 29, 2024, 12:51 |
Insight
Julie Hallet: New study on NETs liver metastases from unknown primary by Patrick Starlinger and team Mayo Clinic
Julie Hallet, Pancreatic and Gastrointestinal Surgical Oncologist at IHPBA, shared a post on LinkedIn: “New study…
May 28, 2024, 14:22 |
Insight
Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer - UCLA Health
Combining immune-targeted therapy with chemotherapy improves both progression-free survival and overall survival when compared to…
May 28, 2024, 07:57 |
Dialogues
Oncothon: Pediatric Oncology with Godfrey Chan, Nita Radhakrishnan
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
May 28, 2024, 07:33 |
Blog
Join chairs Sharlene Gill and Nancy Nixon at Best of ASCO Vancouver - Oncology Education
Sharlene Gill shared a post by Oncology Education adding: .…
May 28, 2024, 04:25 |
Insight
Arndt Vogel: A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas
Arndt Vogel shared on X: “A randomized phase II trial of Captem or Folfiri as…
67
68
69
70
71
All:
1082
Posts:
681 - 690
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO24: 20 Posts Not To Miss From Day 1
Fran Drescher and Uterine Cancer: How She Went Against, How She Survived, and More
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube